Insulin aspart, recombinant Subcutaneous and Prostigmin Bromide
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Prostigmin Bromide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: neostigmine
Brand name: Bloxiverz, Prostigmin
Synonyms: Prostigmin Bromide (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Prostin E2
- Insulin aspart, recombinant Subcutaneous-Prostin VR
- Insulin aspart, recombinant Subcutaneous-Prostin VR Pediatric
- Insulin aspart, recombinant Subcutaneous-Prostin VR Pediatric Intravenous
- Insulin aspart, recombinant Subcutaneous-ProtectIron
- Insulin aspart, recombinant Subcutaneous-Protegra
- Prostigmin Bromide-Insulin degludec
- Prostigmin Bromide-Insulin Degludec (U-100) Prefilled Pens
- Prostigmin Bromide-Insulin Degludec (U-100) Vials
- Prostigmin Bromide-Insulin Degludec (U-200) Prefilled Pens
- Prostigmin Bromide-Insulin degludec and liraglutide
- Prostigmin Bromide-Insulin degludec and liraglutide Subcutaneous